Startrk 2 RXDX 101 02
Research payments
$6,736,548
Through program year 2025, $6,736,548 in research payments was reported against Startrk 2 RXDX 101 02, across 1,778 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $333,339 | 265 |
| 2024 | Research | $542,297 | 233 |
| 2023 | Research | $385,387 | 217 |
| 2022 | Research | $547,176 | 160 |
| 2021 | Research | $1,206,287 | 204 |
| 2020 | Research | $1,287,109 | 349 |
| 2019 | Research | $2,434,951 | 350 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Christine Chung Tampa, FL Named on 88 payments
- Minal Barve Dallas, TX Named on 84 payments
- Manish Patel Sarasota, FL Named on 80 payments
- Stephen Liu Los Angeles, CA Named on 63 payments
- Sherronda Henderson Temple, TX Named on 56 payments
- Daniel Bowles Aurora, CO Named on 50 payments
- Amir Azadi Phoenix, AZ Named on 43 payments
- Ignacio Garrido-Laguna Baltimore, MD Named on 32 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.